The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Benefits and Harms of Computed Tomography Lung Cancer Screening Strategies: A Comparative Modeling Study for the U.S. Preventive Services Task Force
Open accessAbstract
BACKGROUND: The optimum screening policy for lung cancer is unknown. OBJECTIVE: To identify efficient computed tomography (CT) screening scenarios in which relatively more lung cancer deaths are averted for fewer CT screening examinations. DESIGN: Comparative modeling study using 5 independent models. DATA SOURCES: The National Lung Screening Trial; the Prostate, Lung, Colorectal, and Ovarian Cancer Screening trial; the Surveillance, Epidemiology, and End Results program; and the U.S. Smoking History Generator. TARGET POPULATION: U.S. cohort born in 1950. TIME HORIZON: Cohort followed from ages 45 to 90 years. PERSPECTIVE: Societal. INTERVENTION: 576 scenarios with varying eligibility criteria (age, pack-years of smoking, years since quitting) and screening intervals. OUTCOME MEASURES: Benefits included lung cancer deaths averted or life-years gained. Harms included CT examinations, false-positive results (including those obtained from biopsy/surgery), overdiagnosed cases, and radiation-related deaths. RESULTS OF BEST-CASE SCENARIO: The most advantageous strategy was annual screening from ages 55 through 80 years for ever-smokers with a smoking history of at least 30 pack-years and ex-smokers with less than 15 years since quitting. It would lead to 50% (model ranges, 45% to 54%) of cases of cancer being detected at an early stage (stage I/II), 575 screening examinations per lung cancer death averted, a 14% (range, 8.2% to 23.5%) reduction in lung cancer mortality, 497 lung cancer deaths averted, and 5250 life-years gained per the 100,000-member cohort. Harms would include 67,550 false-positive test results, 910 biopsies or surgeries for benign lesions, and 190 overdiagnosed cases of cancer (3.7% of all cases of lung cancer [model ranges, 1.4% to 8.3%]). RESULTS OF SENSITIVITY ANALYSIS: The number of cancer deaths averted for the scenario varied across models between 177 and 862; the number of overdiagnosed cases of cancer varied between 72 and 426. LIMITATIONS: Scenarios assumed 100% screening adherence. Data derived from trials with short duration were extrapolated to lifetime follow-up. CONCLUSION: Annual CT screening for lung cancer has a favorable benefit-harm ratio for individuals aged 55 through 80 years with 30 or more pack-years' exposure to smoking. PRIMARY FUNDING SOURCE: National Cancer Institute.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring the efficiency of decision making units
Charnes, A., Cooper, W. W., & Rhodes, E. (1978) · European Journal of Operational Research · doi:10.1016/0377-2217(78)90138-8 · Cited by 29,767
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Siegel, R., Naishadham, D., & Jemal, A. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21166 · Cited by 11,825
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
Goldstraw, P., Crowley, J., Chansky, K., Giroux, D. J., Groome, P. A., Rami-Porta, R., Postmus, P. E., Rusch, V., & Sobin, L. (2007) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31812f3c1a · Cited by 3,655
The National Lung Screening Trial: Overview and Study Design
National Lung Screening Trial Research Team (2011) · Radiology · doi:10.1148/radiol.10091808 · Cited by 1,274
Benefits and Harms of CT Screening for Lung Cancer: A Systematic Review
Bach, P. B., Mirkin, J. N., Oliver, T. K., Azzoli, C. G., Berry, D. A., Brawley, O. W., Byers, T., Colditz, G. A., Gould, M. K., Jett, J. R., et al. (2012) · JAMA · doi:10.1001/jama.2012.5521 · Cited by 1,244
Selection Criteria for Lung-Cancer Screening
Tammemägi, M. C., Katki, H. A., Hocking, W. G., Church, T. R., Caporaso, N., Kvale, P. A., Chaturvedi, A. K., Silvestri, G. A., Riley, T. L., Commins, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211776 · Cited by 1,029
Self-citationManagement of Lung Nodules Detected by Volume CT Scanning
van Klaveren, R. J., Oudkerk, M., Prokop, M., Scholten, E. T., Nackaerts, K., Vernhout, R., van Iersel, C. A., van den Bergh, K. A. M., van 't Westeinde, S., van der Aalst, C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906085 · Cited by 820
Self-citationDraisma, G., Etzioni, R., Tsodikov, A., Mariotto, A., Wever, E., Gulati, R., Feuer, E., & de Koning, H. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp001 · Cited by 796
Self-citationOken, M. M., Hocking, W. G., Kvale, P. A., Andriole, G. L., Buys, S. S., Church, T. R., Crawford, E. D., Fouad, M. N., Isaacs, C., Reding, D. J., et al. (2011) · JAMA · doi:10.1001/jama.2011.1591 · Cited by 655
Self-citationMandelblatt, J. S., Cronin, K. A., Bailey, S., Berry, D. A., de Koning, H. J., Draisma, G., Huang, H., Lee, S. J., Munsell, M., Plevritis, S. K., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-10-200911170-00010 · Cited by 605
Self-citationZauber, A. G., Lansdorp-Vogelaar, I., Knudsen, A. B., Wilschut, J., van Ballegooijen, M., & Kuntz, K. M. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-9-200811040-00244 · Cited by 581
Targeting of Low-Dose CT Screening According to the Risk of Lung-Cancer Death
Kovalchik, S. A., Tammemagi, M., Berg, C. D., Caporaso, N. E., Riley, T. L., Korch, M., Silvestri, G. A., Chaturvedi, A. K., & Katki, H. A. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301851 · Cited by 575
Self-citationHumphrey, L. L., Deffebach, M., Pappas, M., Baumann, C., Artis, K., Mitchell, J. P., Zakher, B., Fu, R., & Slatore, C. G. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-6-201309170-00690 · Cited by 534
Cardis, E., Gilbert, E. S., Carpenter, L., Howe, G., Kato, I., Armstrong, B. K., Beral, V., Cowper, G., Douglas, A., Fix, J., et al. (1995) · Radiation Research · doi:10.2307/3579020 · Cited by 522
van Iersel, C. A., de Koning, H. J., Draisma, G., Mali, W. P. T. M., Scholten, E. T., Nackaerts, K., Prokop, M., Habbema, J. D. F., Oudkerk, M., & van Klaveren, R. J. (2007) · International Journal of Cancer · doi:10.1002/ijc.22134 · Cited by 494
Self-citationQuality-of-Life Effects of Prostate-Specific Antigen Screening
Heijnsdijk, E. A. M., Wever, E. M., Auvinen, A., Hugosson, J., Ciatto, S., Nelen, V., Kwiatkowski, M., Villers, A., Páez, A., Moss, S. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1201637 · Cited by 427
Self-citationRadzikowska, E., Głaz, P., & Roszkowski, K. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf187 · Cited by 418
Pastorino, U., Rossi, M., Rosato, V., Marchianò, A., Sverzellati, N., Morosi, C., Fabbri, A., Galeone, C., Negri, E., Sozzi, G., et al. (2012) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e328351e1b6 · Cited by 414
Saghir, Z., Dirksen, A., Ashraf, H., Bach, K. S., Brodersen, J., Clementsen, P. F., Døssing, M., Hansen, H., Kofoed, K. F., Larsen, K. R., et al. (2012) · Thorax · doi:10.1136/thoraxjnl-2011-200736 · Cited by 390
Race, socioeconomic status and stage at diagnosis for five common malignancies
Schwartz, K. L., Crossley-May, H., Vigneau, F. D., Brown, K., & Banerjee, M. (2003) · Cancer Causes & Control · doi:10.1023/a:1026321923883 · Cited by 311
Pinsky, P. F., Church, T. R., Izmirlian, G., & Kramer, B. S. (2013) · Cancer · doi:10.1002/cncr.28326 · Cited by 293
Self-citationHoreweg, N., van der Aalst, C. M., Thunnissen, E., Nackaerts, K., Weenink, C., Groen, H. J. M., Lammers, J.-W. J., Aerts, J. G., Scholten, E. T., van Rosmalen, J., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201209-1651oc · Cited by 273
Self-citationVolumetric computed tomography screening for lung cancer: three rounds of the NELSON trial
Horeweg, N., van der Aalst, C. M., Vliegenthart, R., Zhao, Y., Xie, X., Scholten, E. T., Mali, W., Thunnissen, E., Weenink, C., Groen, H. J. M., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00197712 · Cited by 237
Self-citationAnnual number of lung cancer deaths potentially avertable by screening in the United States
Ma, J., Ward, E. M., Smith, R., & Jemal, A. (2013) · Cancer · doi:10.1002/cncr.27813 · Cited by 207
Patterns of Birth Cohort–Specific Smoking Histories, 1965–2009
Holford, T. R., Levy, D. T., McKay, L. A., Clarke, L., Racine, B., Meza, R., Land, S., Jeon, J., & Feuer, E. J. (2014) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2013.10.022 · Cited by 198
Self-citationvan der Aalst, C. M., van den Bergh, K. A. M., Willemsen, M. C., de Koning, H. J., & van Klaveren, R. J. (2010) · Thorax · doi:10.1136/thx.2009.133751 · Cited by 189
Self-citationInterpreting Overdiagnosis Estimates in Population-based Mammography Screening
de Gelder, R., Heijnsdijk, E. A. M., van Ravesteyn, N. T., Fracheboud, J., Draisma, G., & de Koning, H. J. (2011) · Epidemiologic Reviews · doi:10.1093/epirev/mxr009 · Cited by 185
Self-citationImpact of Reduced Tobacco Smoking on Lung Cancer Mortality in the United States During 1975–2000
Moolgavkar, S. H., Holford, T. R., Levy, D. T., Kong, C. Y., Foy, M., Clarke, L., Jeon, J., Hazelton, W. D., Meza, R., Schultz, F., et al. (2012) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs136 · Cited by 184
Self-citationSex-specific trends in lung cancer incidence and survival: a population study of 40 118 cases
Sagerup, C., Småstuen, M. C., Johannesen, T. B., Helland, Å., & Brustugun, O. T. (2011) · Thorax · doi:10.1136/thx.2010.151621 · Cited by 156
de González, A. B., Kim, K. P., & Berg, C. D. (2008) · Journal of Medical Screening · doi:10.1258/jms.2008.008052 · Cited by 119
Self-citationThe impact of a lung cancer computed tomography screening result on smoking abstinence
van der Aalst, C. M., van Klaveren, R. J., van den Bergh, K. A. M., Willemsen, M. C., & de Koning, H. J. (2010) · European Respiratory Journal · doi:10.1183/09031936.00035410 · Cited by 103
That the effects of smoking should be measured in pack-years: misconceptions 4
Peto, J. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.97 · Cited by 96
Meza, R., ten Haaf, K., Kong, C. Y., Erdogan, S. A., Black, W. C., Tammemägi, M. C., Choi, S. E., Jeon, J., Han, S. S., Munshi, V. N., et al. (2014) · Cancer · doi:10.1002/cncr.28623 · Cited by 86
Self-citationChapter 2: Birth‐Cohort‐Specific Estimates of Smoking Behaviors for the U.S. Population
Anderson, C. M., Burns, D., Dodd, K. W., & Feuer, E. J. (2012) · Risk Analysis · doi:10.1111/j.1539-6924.2011.01703.x · Cited by 68
Self-citationChapter 3: Cohort Life Tables by Smoking Status, Removing Lung Cancer as a Cause of Death
Rosenberg, M. A., Feuer, E. J., Yu, B., Sun, J., Henley, S. J., Shanks, T. G., Anderson, C. M., McMahon, P. M., Thun, M. J., & Burns, D. (2012) · Risk Analysis · doi:10.1111/j.1539-6924.2011.01662.x · Cited by 58
Self-citationJeon, J., Meza, R., Krapcho, M. F., Clarke, L. D., Byrne, J. P., & Levy, D. T. (2012) · Risk Analysis · doi:10.1111/j.1539-6924.2011.01775.x · Cited by 56
Self-citationGender differences in non-small cell lung cancer: A population-based study
Caldarella, A., Crocetti, E., Comin, C., Janní, A., Pegna, A. L., & Paci, E. (2007) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2007.01.001 · Cited by 49
Prostate cancer diagnosis: The impact on patients’ mental health
Korfage, I. J., de Koning, H. J., Roobol, M. J., Schröder, F. H., & Essink‐Bot, M. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.10.011 · Cited by 49
van der Aalst, C. M., van Klaveren, R. J., & de Koning, H. J. (2010) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2010.06.001 · Cited by 31
Cited by
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial
de Koning, H. J., van der Aalst, C. M., de Jong, P. A., Scholten, E. T., Nackaerts, K., Heuvelmans, M. A., Lammers, J.-W. J., Weenink, C., Yousaf-Khan, U., Horeweg, N., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1911793 · Cited by 3,624
Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2014) · Annals of Internal Medicine · doi:10.7326/m13-2771 · Cited by 2,632
Cancer health disparities in racial/ethnic minorities in the United States
Zavala, V. A., Bracci, P. M., Carethers, J. M., Carvajal-Carmona, L., Coggins, N. B., Cruz-Correa, M. R., Davis, M., de Smith, A. J., Dutil, J., Figueiredo, J. C., et al. (2021) · British Journal of Cancer · doi:10.1038/s41416-020-01038-6 · Cited by 912
Amann, A., Costello, B. D. L., Miekisch, W., Schubert, J., Buszewski, B., Pleil, J., Ratcliffe, N., & Risby, T. (2014) · Journal of Breath Research · doi:10.1088/1752-7155/8/3/034001 · Cited by 804
Smith, R. A., Andrews, K. S., Brooks, D., Fedewa, S. A., Manassaram‐Baptiste, D., Saslow, D., Brawley, O. W., & Wender, R. C. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21392 · Cited by 719
Metadata
- Authors
- de Koning, H. J., Meza, R., Plevritis, S. K., ten Haaf, K., Munshi, V. N., Jeon, J., Erdogan, S. A., Kong, C. Y., Han, S. S., van Rosmalen, J., Choi, S. E., Pinsky, P. F., de Gonzalez, A. B., Berg, C. D., Black, W. C., Tammemägi, M. C., Hazelton, W. D., Feuer, E. J., & McMahon, P. M.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2014-03-04
- Volume
- 160
- Issue
- 5
- Pages
- 311-320
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2161254570
- Cited by
- 466
- References
- 41
- FWCI
- 35.08
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.